Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Danylo Palomino-Mendoza"'
Autor:
Borja Puertas-Martinez, Luz Gema Roman-Molano, Alejandro Avendaño-Pita, Noemi Puig-Moron, Sandra Patricia Gomez-Ubeda, Mónica Baile-González, Alberto Hernandez-Sanchez, Verónica González-de la Calle, Danylo Palomino-Mendoza, Sara Marcos Asensio, María Victoria Mateos-Manteca, Almudena Cabero-Martínez, Felipe Peña-Muñoz
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S254
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aabb0f21fc18b926e2c269189a615c58
https://doi.org/10.1016/s2152-2650(21)01591-3
https://doi.org/10.1016/s2152-2650(21)01591-3
Autor:
Felipe Peña-Muñoz, Luz Román-Molano, Danylo Palomino-Mendoza, Alberto Hernández-Sánchez, Borja Puertas-Martínez, Sandra Gómez-Úbeda, Mónica Baile-González, Almudena Cabero-Martínez, Alejandro Avendaño-Pita, Sara Marcos Asensio, Verónica González-de la Calle, Noemi Puig-Moron, María Victoria Mateos-Manteca
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S433
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc1a35488d29faedad593de4c2a33324
https://doi.org/10.1016/s2152-2650(21)01966-2
https://doi.org/10.1016/s2152-2650(21)01966-2
Autor:
Fermín Sánchez-Guijo, Laura Prieto Garcia, Marta Fonseca Santos, Lucía López Corral, Raúl Azibeiro Melchor, Mónica Baile González, María Dolores Caballero Barrigón, Miriam Lopez Parra, Mónica Cabrero Calvo, Luz Gema Román Molano, Alejandro Martin Garcia-Sancho, Estefania Pérez López, Miguel Alcoceba, Óscar Blanco Múñez, Beatriz Rey Búa, Maria Cortés Rodriguez, Borja Puertas Martinez, Sandra Patricia Gomez Úbeda, Norma C. Gutiérrez, Alberto Hernández Sánchez, Lourdes Lopez, Danylo Palomino Mendoza, Ana Africa Martín López, Pilar Tamayo Alonso, Andres Felipe Peña Muñoz
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S278-S279
Context: Outcomes of patients with transformed lymphoma have historically been poor, prompting many centres to include stem-cell transplant (SCT) as part of the treatment strategy. However, several studies in the rituximab era suggest that survival m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a1b61dbf327fa4f8c5fd8cbb9afc783
https://doi.org/10.1016/s2152-2650(20)30899-5
https://doi.org/10.1016/s2152-2650(20)30899-5
Autor:
Alberto Hernandez-Sanchez, Monica Cabrero, Maria Dolores Caballero, Ana A. Martín, María Teresa García-Álvarez, Mónica Baile, Estefania Perez, Raul Azibeiro-Melchor, Danylo Palomino-Mendoza, Lucía López-Corral, Fermín Sánchez-Guijo, Miguel Alcoceba, Beatriz Rey-Bua, Luz Gema Roman-Molano, Sandra Patricia Gomez-Ubeda, Marta Garcia-Blazquez, Luis A. Corchete-Sánchez, Lourdes Vázquez, Felipe Peña-Muñoz, Borja Puertas-Martinez, Manuela Salinero, Marta Fonseca-Santos
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S215-S216
Context Recent studies have described the importance of Suppressor of Tumorigenicity-2 (ST2) and Regenerating islet-derived 3a (REG3a) serum biomarkers in allogenic stem-cell-transplantation. Only two studies have focused on haploidentical stem-cell-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::debc8fca43cdcbedb058dd6cc9d6685d
https://doi.org/10.1016/s2152-2650(20)30781-3
https://doi.org/10.1016/s2152-2650(20)30781-3